NJ Top Docs has reviewed and approved five physicians at Hunterdon Hematology Oncology for 2026. We are incredibly ...

A meta-analysis of 13 studies showed that patients who underwent sentinel node biopsy had a significantly reduced risk of death from melanoma. In addition, an analysis of nine studies showed that the ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Richard Ingram, MD, FASCO, is president of the Virginia Association of Hematology and Oncology and a member of the Community ...

Colonoscopy” and “cool” are rarely uttered in the same sentence.Yet, Shikha Jain, MD, FACP, associate professor of medicine ...

MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for ...

Lonial emphasizes that the EXCALIBER-RRMM trial is a test case for a new regulatory framework. The study utilizes dual primary end points to satisfy both accelerated and full approval requirements: ...

News, features, and commentary about cancer-related issues ...

Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...